All Updates

All Updates

icon
Filter
Management news
Cibus announces proposed public offering of Class A common stock
Crop Biotech
Sep 17, 2024
This week:
Product updates
Alibaba Cloud launches revamped full-stack AI infrastructure to support development of AI models
Generative AI Infrastructure
Yesterday
Funding
Twelve raises USD 645 million in funding to transform CO2 into jet fuel
Alternative Energy
Sep 19, 2024
Funding
Air Company raises USD 69 million in Series B funding to commercialize carbon utilization technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 19, 2024
Funding
Twelve raises USD 645 million in funding to transform CO2 into jet fuel
Carbon Capture, Utilization & Storage (CCUS)
Sep 19, 2024
Funding
LinkGevity receives TechEU grant to accelerate technology developments for AI drug discovery
AI Drug Discovery
Sep 19, 2024
Partnerships
CS Genetics and Rosalind partner to enhance single-cell genomic R&D
Precision Medicine
Sep 19, 2024
Funding
Hippocratic AI raises USD 17 million in extended Series A funding from NVentures
Generative AI Applications
Sep 19, 2024
Industry news
Partnerships
Tallinn partners with Hayden AI to pilot automated bus lane monitoring
Smart Mobility Information
Sep 19, 2024
Product updates
Alibaba releases over 100 open-source AI models and text-to-video tool
Foundation Models
Sep 19, 2024
Product updates
Partnerships
AssemblyAI partners with Activepieces to offer speech AI capabilities
Foundation Models
Sep 19, 2024
Crop Biotech

Crop Biotech

Sep 17, 2024

Cibus announces proposed public offering of Class A common stock

Management news

  • Cibus, Inc., an agricultural biotechnology company, announced its intention to offer shares of Class A common stock in an underwritten public offering.

  • The company plans to grant underwriters a 45-day option to purchase up to 15% of the offered shares. Roth Capital Partners and A.G.P./Alliance Global Partners are acting as joint book-running managers for the offering.

  • Cibus intends to use the net proceeds to fund the development of new seed traits, improve existing ones, support Trait Machine operations, and for working capital and general corporate purposes.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.